Compass Therapeutics, Inc. financial data

Symbol
CMPX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Olivia Ventures, Inc. (to 6/8/2020)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.37K % +51.9%
Debt-to-equity 5.54 % -26.4%
Return On Equity -32.4 % -36.3%
Return On Assets -30.7 % -39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 138M shares +7.93%
Common Stock, Shares, Outstanding 138M shares +7.96%
Entity Public Float 283M USD +53.8%
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 138M shares +7.98%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 14.6M USD +18.9%
Operating Income (Loss) -55.4M USD -15.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.2M USD -10.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -47.8M USD -17.4%
Earnings Per Share, Basic -0.36 USD/shares -9.09%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.8M USD +21%
Marketable Securities, Current 98.6M USD -26%
Cash, Cash Equivalents, and Short-term Investments 175M USD
Assets, Current 141M USD -15.3%
Property, Plant and Equipment, Net 493K USD -53.1%
Operating Lease, Right-of-Use Asset 6.95M USD +234%
Other Assets, Noncurrent 568K USD +77.5%
Assets 149M USD -12.3%
Accounts Payable, Current 960K USD -58.4%
Accrued Liabilities, Current 2.92M USD -48.3%
Liabilities, Current 4.43M USD -51.4%
Operating Lease, Liability, Noncurrent 6.32M USD +627%
Liabilities 10.8M USD +7.61%
Accumulated Other Comprehensive Income (Loss), Net of Tax 486K USD
Retained Earnings (Accumulated Deficit) -350M USD -15.8%
Stockholders' Equity Attributable to Parent 138M USD -13.5%
Liabilities and Equity 149M USD -12.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.9M USD -13.6%
Net Cash Provided by (Used in) Financing Activities 17.4M USD +42420%
Net Cash Provided by (Used in) Investing Activities -4.1M USD -196%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 138M shares +7.93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -554K USD +93%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Gross 44.3M USD +53.6%
Operating Lease, Liability 6.88M USD +237%
Depreciation 200K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.8M USD -15.8%
Lessee, Operating Lease, Liability, to be Paid 8.57M USD +299%
Property, Plant and Equipment, Gross 7.21M USD +0.74%
Operating Lease, Liability, Current 557K USD -52.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD +87.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 733K USD -46.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.69M USD +1540%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD
Operating Lease, Payments 1.3M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 485K USD -40%
Share-based Payment Arrangement, Expense 7.92M USD +42.9%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%